Correlation Between Verona Pharma and MiMedx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verona Pharma and MiMedx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and MiMedx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verona Pharma PLC and MiMedx Group, you can compare the effects of market volatilities on Verona Pharma and MiMedx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of MiMedx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and MiMedx.

Diversification Opportunities for Verona Pharma and MiMedx

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Verona and MiMedx is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and MiMedx Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MiMedx Group and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with MiMedx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MiMedx Group has no effect on the direction of Verona Pharma i.e., Verona Pharma and MiMedx go up and down completely randomly.

Pair Corralation between Verona Pharma and MiMedx

Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 0.95 times more return on investment than MiMedx. However, Verona Pharma PLC is 1.05 times less risky than MiMedx. It trades about 0.09 of its potential returns per unit of risk. MiMedx Group is currently generating about 0.07 per unit of risk. If you would invest  1,886  in Verona Pharma PLC on November 1, 2024 and sell it today you would earn a total of  3,838  from holding Verona Pharma PLC or generate 203.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Verona Pharma PLC  vs.  MiMedx Group

 Performance 
       Timeline  
Verona Pharma PLC 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
MiMedx Group 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MiMedx Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, MiMedx reported solid returns over the last few months and may actually be approaching a breakup point.

Verona Pharma and MiMedx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verona Pharma and MiMedx

The main advantage of trading using opposite Verona Pharma and MiMedx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, MiMedx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiMedx will offset losses from the drop in MiMedx's long position.
The idea behind Verona Pharma PLC and MiMedx Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements